Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Targeting specific T cells may help treat alopecia areata.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The Fas/FasL pathway may play a role in alopecia areata.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Targeting Vδ1+T-cells may help treat alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Arg1+ macrophages may play a role in causing alopecia areata.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Certain NK cell changes in blood may indicate alopecia areata progression.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

PCFCL may have unrecognized subtypes and needs more research.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.